87.2025 Management And Monitoring Of Non -Commercial Clinical Trial Entitled "Open Single-Eye Monitoring With Dose Escalation To Assess The Safety Of Locally Produced Car-T Anti-Cd19 Lymphocytes In Adults With Aggressive Lymphomas From Mature B Lymphocytes In The Treatment Of The Second Line (Carmen)"